Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla
NCT ID: NCT03200457
Last Updated: 2022-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
92 participants
INTERVENTIONAL
2018-07-20
2020-08-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
NCT02099214
Liver Fat and Iron Quantification MRI
NCT03162302
Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T
NCT00554073
Massive Iron Deposit Assessment
NCT01572922
Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron Overload
NCT00675038
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with hepatic iron overload or steatosis
Each patient (80) will have two MRI exams on the same day: one performed in common practice on a 1.5 Tesla device and the other on a 3 Tesla device.
1,5 Tesla abdominal MRI
Measurement of the fat and iron
3 Tesla abdominal MRI
Measurement of the fat and iron
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1,5 Tesla abdominal MRI
Measurement of the fat and iron
3 Tesla abdominal MRI
Measurement of the fat and iron
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having an MRI indication of iron and fat quantification;
* Benefiting from social security;
* Having given a free, informed and written consent.
Exclusion Criteria
* Implantable cardiac pacemaker or defibrillator;
* Non-MRI cardiac valve compatible;
* Clips, stents, coils, etc ... no MRI compatible;
* Cochlear implants;
* Neuronal or peripheral stimulator;
* Foreign bodies metallic intra orbital or encephalic, foreign body close to the eyes, wound by metallic lash (war, ball);
* Endoprostheses placed for less than 4 weeks and osteosynthesis materials placed less than 6 weeks old;
* Claustrophobia;
* Pumps, tattoos, permanent make-up, intrauterine device, patches;
* Metallic, magnetic, non-removable material and close to the analysis field.
Other criteria
* unstable hemodynamic status, acute respiratory failure, general precarious condition or a need for continuous monitoring incompatible with MRI constraints;
* Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.
* Known pregnancy, breastfeeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yves Gandon, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital St Vincent du Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, , France
CHU de Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01291-52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.